H2020 Innovative Medicines Initiative

LITMUS

LITMUS aims to develop, validate and qualify biomarkers that diagnose, risk stratify and/or monitor NAFLD/NASH progression and fibrosis stage.

Funding European Commission, Horizon 2020
Call/Topic H2020-JTI-IMI2-2016-09-05
Project reference 777377
Title Liver Investigation: Testing Marker Utility in Steatohepatitis
Start date 1 November 2017
Duration 60 months
Total cost EUR 32 472 404,00
Project Coordinator Quentin M. Anstee
Participants EFPIA companies
Boehringer Ingelheim International GmbH, Ingelheim, Germany
Eli Lilly and Company Ltd, Basingstoke, United Kingdom
Ellegaard Gottingen Minipigs As
Genfit
Intercept Pharma Europe LTD
Novartis Pharma AG, Basel, Switzerland
Novo Nordisk A/S, Bagsvaerd, Denmark
Pfizer Limited, Sandwich, Kent , United Kingdom
Sanofi-Aventis Deutschland GMBH, Frankfurt / Main, Germany
Takeda Development Centre Europe Ltd., London, United Kingdom

Universities, research organisations, public bodies, non-profit groups
Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, Netherlands
Asociacion Centro De Investigacion Cooperativa En Biociencias
European Association For The Studyof The Liver
Faculdade de Medicina da Universidade de Lisboa
iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa; Cecília M. P. Rodrigues
Hôpital de la Salpêtrière, Paris , France
Institute of Cardiometabolism And Nutrition, Paris, France
Linkopings Universitet, Linkoping, Sweden
Luxembourg Institute of Health / Integrated Biobank of Luxembourg, Luxembourg, Luxembourg
Medizinische Universitaet Wien, Vienna, Austria
National & Kapodistrian University of Athens, Athens, Greece
Orebro University
Servicio Andaluz de Salud, Sevilla, Spain
UNIVERSITAETSKLINIKUM Aachen, Aachen, Germany
Universita Degli Studi Di Palermo
Universita Degli Studi Di Torino, Turin, Italy
Universitaetsklinikum Wuerzburg – Klinikum Der Bayerischen Julius-Maximilians-Universitat
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany
Universitair Medisch Centrum Utrecht , Utrecht, Netherlands
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Universite D’Angers
University of Birmingham, Birmingham, United Kingdom
University of Cambridge, Cambridge, United Kingdom
University of Helsinki, University of Helsinki, Helsinki, Finland
University of Nottingham, Nottingham, United Kingdom
University of Oxford, Oxford, United Kingdom
Università Cattolica del Sacro Cuore, Milan, Italy
Università degli Studi di Milano, Milano, Italy
Universität Bern, Bern, Switzerland

Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
Antaros Medical AB, Mölndal, Sweden
Exalenz Bioscience LTD
Ixscient Limited
Nordic Bioscience A/S, Herlev, Denmark
One Way Liver SL
Perspectum Diagnostics LTD
SomaLogic, Inc., Boulder, United States